Targeted Drug for Advanced Pancreatic Cancer Sparks Early Enthusiasm

By News Health
1 month Ago

(MedPage Today) — SAN FRANCISCO — Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease control with a novel KRAS G12D inhibitor, a small preliminary study showed.
The early results showed that…

Source link : https://www.medpagetoday.com/meetingcoverage/mgics/119372

Author :

Publish date : 2026-01-10 14:01:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Quiz Time: Was Coffee Linked to Higher Dementia Risk?

State Abortion Bans Tied to Spike in Maternal Death Rates

Using the EHR to Deprescribe Risky Meds; Knee Braces for Osteoarthritis

Medical Education Must Go Beyond Individual Pathology

Colorectal Cancer Is Rising in Younger Adults. Who's At Risk and What Are the Signs?

What These 5 Women Want You to Know